Bepotastine
Class: Antiallergic Agents
- Histamine H1-receptor Antagonists
- Mast-cell Stabilizers
Chemical Name: 4-[(S)-(4-chlorophenyl)-2-pyridinylmethoxy]-,benzene sulfonate (1:1); (2) (+)-4-{4-[(S)-(4-Chlorophenyl)(pyridin-2-yl)methoxy]piperidin-1-yl}butanoic acid monobenzenesulfonate.
Molecular Formula: C21H25ClN2O3.C6H6O3S.547.10
CAS Number: 190786-44-8
Brands: Bepreve
Introduction
Histamine H 1-receptor antagonist with mass-cell stabilizing activity.
Uses for Bepotastine
Allergic Conjunctivitis
Symptomatic treatment of ocular itching associated with allergic conjunctivitis.
Bepotastine Dosage and Administration
Administration
Ophthalmic Administration
Apply topically to the eye as an ophthalmic solution.
Remove soft contact lenses prior to administration of each dose (since benzalkonium chloride may be absorbed by the lenses); may reinsert lenses after 10 minutes following administration if eyes are not red.
Avoid contamination of the solution container.
Dosage
Available as bepotastine besilate; dosage expressed in terms of the salt.
Pediatric Patients
Allergic Conjunctivitis
Ophthalmic
Children ≥2 years of age: 1 drop of a 1.5% solution in the affected eye(s) twice daily.
Adults
Allergic Conjunctivitis
Ophthalmic
1 drop of a 1.5% solution in the affected eye(s) twice daily.
Cautions for Bepotastine
Contraindications
Manufacturer states none known.
Warnings/Precautions
Administration
For topical ophthalmic use only.
Proper Handling to Avoid Contamination
To avoid contamination of the dropper tip and solution, do not to touch the eyelids or surrounding areas with the dropper tip.
Close container tightly when not in use.
Contact Lenses
Remove contact lenses prior to administration of each dose, since benzalkonium chloride preservative may be absorbed by soft contact lenses; lenses may be reinserted after 10 minutes following administration if eyes are not red; patient should not wear contact lenses if eyes are red. Not indicated for contact lens-related ocular irritation.
Specific Populations
Pregnancy
Category C.
Lactation
Distributed into milk in rats following oral administration.
Not known whether bepotastine besilate distributes into human milk following topica.